Amedeo Smart

Free Medical Literature Service


 

Amedeo

Dermatology

  Free Subscription

Articles published in
N Engl J Med
    July 2022
  1. PIVOT X
    Pembrolizumab in the Treatment of Breast Cancer.
    N Engl J Med. 2022;387:273-274.
    >> Share

  2. CORTES J, Rugo HS, Cescon DW, Im SA, et al
    Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer.
    N Engl J Med. 2022;387:217-226.
    >> Share

  3. HUNG WK, Chung WH
    Drug Reaction with Eosinophilia and Systemic Symptoms.
    N Engl J Med. 2022;387:167.
    >> Share

  4. HURVITZ SA
    DESTINY-Changing Results for Advanced Breast Cancer.
    N Engl J Med. 2022;387:75-76.
    >> Share

    June 2022
  5. JATOI I, Sung H, Jemal A
    The Emergence of the Racial Disparity in U.S. Breast-Cancer Mortality.
    N Engl J Med. 2022;386:2349-2352.
    >> Share

  6. ROKHZAN R, Meier K
    Targeted Therapy in Melanoma.
    N Engl J Med. 2022;386:e66.
    >> Share

  7. CORTES J, Im SA, Cathcart J
    Trastuzumab Deruxtecan for Breast Cancer. Reply.
    N Engl J Med. 2022;386:2347.
    >> Share

  8. ZHENG F, Du F, Yuan P
    Trastuzumab Deruxtecan for Breast Cancer.
    N Engl J Med. 2022;386:2346-2347.
    >> Share

  9. MODI S, Jacot W, Yamashita T, Sohn J, et al
    Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer.
    N Engl J Med. 2022 Jun 5. doi: 10.1056/NEJMoa2203690.
    >> Share

    May 2022
  10. FAJGENBAUM DC, Goiffon RJ, Soumerai JD, Harris CK, et al
    Case 16-2022: A 55-Year-Old Man with Fevers, Night Sweats, and a Mediastinal Mass.
    N Engl J Med. 2022;386:2036-2048.
    >> Share

  11. TAWBI HA, Hodi FS, Long GV
    Nivolumab with or without Relatlimab in Untreated Advanced Melanoma. Reply.
    N Engl J Med. 2022;386:1860-1861.
    >> Share

  12. HINDIE E
    Nivolumab with or without Relatlimab in Untreated Advanced Melanoma.
    N Engl J Med. 2022;386:1860.
    >> Share

  13. ALHATEM A, Smith KC
    Primary Cutaneous Blastomycosis.
    N Engl J Med. 2022;386:e49.
    >> Share

  14. SCHMID P, Cortes J, Dent R
    Pembrolizumab in Early Triple-Negative Breast Cancer. Reply.
    N Engl J Med. 2022;386:1771-1772.
    >> Share

  15. GANGULY S, Gogia A
    Pembrolizumab in Early Triple-Negative Breast Cancer.
    N Engl J Med. 2022;386:1771.
    >> Share

  16. MESSENGER A, Harries M
    Baricitinib in Alopecia Areata.
    N Engl J Med. 2022;386:1751-1752.
    >> Share

  17. KING B, Ohyama M, Kwon O, Zlotogorski A, et al
    Two Phase 3 Trials of Baricitinib for Alopecia Areata.
    N Engl J Med. 2022;386:1687-1699.
    >> Share

    April 2022
  18. BRYANT-STEPHENS T
    Breaking the Skin Color Barriers for Asthma Medications - It's Not Black, Brown, or White.
    N Engl J Med. 2022;386:1574-1575.
    >> Share

    March 2022
  19. CORTES J, Kim SB, Chung WP, Im SA, et al
    Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer.
    N Engl J Med. 2022;386:1143-1154.
    >> Share

  20. ZHANG P, Chen L
    Melanoma of the Palpebral Conjunctiva and Eyelid.
    N Engl J Med. 2022 Mar 19. doi: 10.1056/NEJMicm2115699.
    >> Share

  21. LONGHURST HJ, Ameratunga R
    An Antisense Oligonucleotide for Hereditary Angioedema.
    N Engl J Med. 2022;386:1083-1085.
    >> Share

  22. BANERJI A, Phadke NA, Gottumukkala R, Sharma R, et al
    Case 8-2022: A 54-Year-Old Woman with Episodes of Swelling.
    N Engl J Med. 2022;386:1071-1079.
    >> Share

  23. LUEKING R, Lazarte S
    Malignant Syphilis.
    N Engl J Med. 2022;386:e26.
    >> Share

  24. FIJEN LM, Riedl MA, Bordone L, Bernstein JA, et al
    Inhibition of Prekallikrein for Hereditary Angioedema.
    N Engl J Med. 2022;386:1026-1033.
    >> Share

  25. ALAGESAN M, Chidambaram Y
    Pellagra.
    N Engl J Med. 2022;386:e24.
    >> Share

  26. HORTOBAGYI GN, Stemmer SM, Burris HA, Yap YS, et al
    Overall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer.
    N Engl J Med. 2022;386:942-950.
    >> Share

    February 2022
  27. LEUNG TH, Cotsarelis G
    Cellular Memories - More Than Skin Deep.
    N Engl J Med. 2022;386:793-795.
    >> Share

  28. SILVERMAN RF, Shinder R
    Molluscum Contagiosum.
    N Engl J Med. 2022;386:582.
    >> Share

  29. SCHMID P, Cortes J, Dent R, Pusztai L, et al
    Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer.
    N Engl J Med. 2022;386:556-567.
    >> Share

  30. YOKOYAMA T
    Chronic Generalized Pruritus.
    N Engl J Med. 2022;386:e12.
    >> Share

  31. BRAGA NETO MB, Badley AD, Parikh SA, Graham RP, et al
    Calm before the Storm.
    N Engl J Med. 2022;386:479-485.
    >> Share

    January 2022
  32. GRAYSON PC, Perugino CA, Dinculescu VV, Ferry JA, et al
    Case 2-2022: A 70-Year-Old Man with a Recurrent Left Pleural Effusion.
    N Engl J Med. 2022;386:274-283.
    >> Share

  33. MAHARAJH S, Teelucksingh S
    Hyperpigmentation in Vitamin B12 Deficiency.
    N Engl J Med. 2022;386:172.
    >> Share

  34. FRAMPTON AE, Sivakumar S
    A New Combination Immunotherapy in Advanced Melanoma.
    N Engl J Med. 2022;386:91-92.
    >> Share

  35. TAWBI HA, Schadendorf D, Lipson EJ, Ascierto PA, et al
    Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma.
    N Engl J Med. 2022;386:24-34.
    >> Share

  36. JOHN LN, Beiras CG, Houinei W, Medappa M, et al
    Trial of Three Rounds of Mass Azithromycin Administration for Yaws Eradication.
    N Engl J Med. 2022;386:47-56.
    >> Share

    December 2021
  37. SHARMA V, Kumar A
    Carcinoma en Cuirasse.
    N Engl J Med. 2021;385:2562.
    >> Share

  38. BACHELEZ H, Choon SE, Marrakchi S, Burden AD, et al
    Trial of Spesolimab for Generalized Pustular Psoriasis.
    N Engl J Med. 2021;385:2431-2440.
    >> Share

  39. KATAYAMA S, Ota M
    Minocycline-Induced Hyperpigmentation.
    N Engl J Med. 2021;385:2463.
    >> Share

  40. KALINSKY K, Barlow WE, Gralow JR, Meric-Bernstam F, et al
    21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer.
    N Engl J Med. 2021;385:2336-2347.
    >> Share

  41. WILLETT LL, Bromberg GK, Chung R, Leaf RK, et al
    Case 38-2021: A 76-Year-Old Woman with Abdominal Pain, Weight Loss, and Memory Impairment.
    N Engl J Med. 2021;385:2378-2388.
    >> Share

  42. DILLY B, Bomahou C
    Tongue Necrosis in Giant-Cell Arteritis.
    N Engl J Med. 2021;385:2377.
    >> Share

  43. MCKINLEY TD, Maroon M
    Linear Darier's Disease.
    N Engl J Med. 2021;385:e91.
    >> Share

  44. BIEBER T
    AhR Modulating Agent for the Topical Therapy of Plaque Psoriasis.
    N Engl J Med. 2021;385:2295-2296.
    >> Share

  45. LEBWOHL MG, Stein Gold L, Strober B, Papp KA, et al
    Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis.
    N Engl J Med. 2021;385:2219-2229.
    >> Share

  46. KUECKELHAUS M, Rothoeft T, De Rosa L, Yeni B, et al
    Transgenic Epidermal Cultures for Junctional Epidermolysis Bullosa - 5-Year Outcomes.
    N Engl J Med. 2021;385:2264-2270.
    >> Share

  47. WALLACE ZS, Rodriguez K, Dau J, Bloch DB, et al
    Case 37-2021: A 60-Year-Old Man with Fevers, Fatigue, Arthralgias, a Mouth Ulcer, and a Rash.
    N Engl J Med. 2021;385:2282-2293.
    >> Share

  48. KALLESH A, Kumar VS
    Congenital Langerhans-Cell Histiocytosis.
    N Engl J Med. 2021;385:e86.
    >> Share

    November 2021
  49. WINSTON LG, Winkler ML, Kheterpal A, Villalba JA, et al
    Case 36-2021: A 22-Year-Old Man with Pain and Erythema of the Left Hand.
    N Engl J Med. 2021;385:2078-2086.
    >> Share

  50. WANG T, Chen JQ
    Tinea Capitis Due to Microsporum canis.
    N Engl J Med. 2021;385:2077.
    >> Share

  51. VARONI EM, Decani S
    Gingival Melanoma.
    N Engl J Med. 2021;385:e73.
    >> Share

  52. DIETZ BW, Winston LG, Koehler JE, Margaretten M, et al
    Copycat.
    N Engl J Med. 2021;385:1797-1802.
    >> Share

    October 2021
  53. ASKENASE PW
    Rare Skin Reactions after mRNA Vaccination, Similar to Jones-Mote Basophil Responses.
    N Engl J Med. 2021;385:1720-1721.
    >> Share

  54. AKINTILO L, Femia A
    Disseminated Cryptococcosis.
    N Engl J Med. 2021;385:1699.
    >> Share

  55. RAMIREZ-LLUCH M, Hernandez-Martin A
    Pearly Penile Papules.
    N Engl J Med. 2021;385:1420.
    >> Share

  56. TUTT ANJ, Garber JE, Geyer CE Jr
    Adjuvant Olaparib in BRCA-Mutated Breast Cancer. Reply.
    N Engl J Med. 2021;385:1440.
    >> Share

  57. HOSHI A, Bando H, Sekine I
    Adjuvant Olaparib in BRCA-Mutated Breast Cancer.
    N Engl J Med. 2021;385:1439-1440.
    >> Share

  58. NOZAWA K, Yoshimura A, Iwata H
    Adjuvant Olaparib in BRCA-Mutated Breast Cancer.
    N Engl J Med. 2021;385:1439.
    >> Share

    September 2021
  59. LINDSAY ME, Dudzinski DM, Yoon BC, Jaff MR, et al
    Case 30-2021: A 47-Year-Old Man with Recurrent Unilateral Head and Neck Pain.
    N Engl J Med. 2021;385:1317-1325.
    >> Share

  60. BARRY D, Schmieder A
    Leukemia Cutis.
    N Engl J Med. 2021;385:1316.
    >> Share

  61. TSUI JC, Onishi S
    Symblepharon in Linear IgA Bullous Dermatosis.
    N Engl J Med. 2021;385:1219.
    >> Share

  62. NATHAN P, Hassel JC, Rutkowski P, Baurain JF, et al
    Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma.
    N Engl J Med. 2021;385:1196-1206.
    >> Share

  63. WARREN RB, Cioffi C, Peterson L
    Bimekizumab versus Adalimumab in Plaque Psoriasis. Reply.
    N Engl J Med. 2021;385:1150.
    >> Share

  64. GRIFFITH SK, Ahn GS, Wu JJ
    Bimekizumab versus Adalimumab in Plaque Psoriasis.
    N Engl J Med. 2021;385:1149-1150.
    >> Share

  65. GOUVEIA-MORAES F, Campos N
    Conjunctival Kaposi's Sarcoma.
    N Engl J Med. 2021;385:e36.
    >> Share

  66. WERTH VP, Joly P, Chen DM
    Rituximab versus Mycophenolate Mofetil in Pemphigus Vulgaris. Reply.
    N Engl J Med. 2021;385:1056.
    >> Share

  67. HOPKINS ZH, Wu BC, Nousari CH
    Rituximab versus Mycophenolate Mofetil in Pemphigus Vulgaris.
    N Engl J Med. 2021;385:1055-1056.
    >> Share

  68. MERGOUM AM
    Amoxicillin Rash in Infectious Mononucleosis.
    N Engl J Med. 2021;385:1033.
    >> Share

    August 2021
  69. AKBARI K, Sgromo B
    Intussusception in the Peutz-Jeghers Syndrome.
    N Engl J Med. 2021;385:744.
    >> Share

  70. SCHETT G, McInnes IB, Neurath MF
    Reframing Immune-Mediated Inflammatory Diseases through Signature Cytokine Hubs.
    N Engl J Med. 2021;385:628-639.
    >> Share

  71. FREDRICK TW, Neto MBB, Johnsrud DO, Camilleri M, et al
    Turning Purple with Pain.
    N Engl J Med. 2021;385:549-554.
    >> Share

  72. BEATTY CJ, Ghareeb ER
    Neutrophilic Eccrine Hidradenitis.
    N Engl J Med. 2021;385:e19.
    >> Share

    July 2021
  73. GOODWIN PJ
    Extended Aromatase Inhibitors in Hormone-Receptor-Positive Breast Cancer.
    N Engl J Med. 2021;385:462-463.
    >> Share

  74. MARINHO-SOARES C, Pulido-Valente M
    Axillary Mass after Delivery.
    N Engl J Med. 2021;385:450.
    >> Share

  75. GNANT M, Fitzal F, Rinnerthaler G, Steger GG, et al
    Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer.
    N Engl J Med. 2021;385:395-405.
    >> Share

  76. COLQUHOUN M, Penn H
    Salt-and-Pepper Skin Changes in Systemic Sclerosis.
    N Engl J Med. 2021;385:357.
    >> Share

  77. AYYASH AM, Sampath R
    Acute Febrile Neutrophilic Dermatosis.
    N Engl J Med. 2021;385:e14.
    >> Share

  78. BARDIA A, Hurvitz SA, Rugo HS
    Sacituzumab Govitecan in Metastatic Breast Cancer. Reply.
    N Engl J Med. 2021;385:e12.
    >> Share

  79. GANGULY S, Gogia A
    Sacituzumab Govitecan in Metastatic Breast Cancer.
    N Engl J Med. 2021;385:e12.
    >> Share

  80. KORMAN TM
    Moving beyond "Red Man Syndrome".
    N Engl J Med. 2021;385:192.
    >> Share

  81. FENG X, Qi H
    Phthiriasis Palpebrarum.
    N Engl J Med. 2021;385:e5.
    >> Share

  82. GOGLIN SE, Margaretten ME
    Malar Rash.
    N Engl J Med. 2021;385:164.
    >> Share

  83. PISCHEL L, Geirsson A, Magaldi J, Martinello RA, et al
    A Brewing Back Pain.
    N Engl J Med. 2021;385:66-72.
    >> Share

    June 2021
  84. O'CONNELL KA, LaChance AH
    Dermatomyositis.
    N Engl J Med. 2021;384:2437.
    >> Share

  85. SEEKER P, Osswald S
    Tongue Discoloration.
    N Engl J Med. 2021;384:e102.
    >> Share

  86. WERTH VP, Joly P, Mimouni D, Maverakis E, et al
    Rituximab versus Mycophenolate Mofetil in Patients with Pemphigus Vulgaris.
    N Engl J Med. 2021;384:2295-2305.
    >> Share

  87. CURTI BD, Faries MB
    Recent Advances in the Treatment of Melanoma.
    N Engl J Med. 2021;384:2229-2240.
    >> Share

  88. PATEL TS, Teterina Mohammed E
    Porphyria Cutanea Tarda Associated with Hepatitis C.
    N Engl J Med. 2021;384:e86.
    >> Share

  89. BECK DB, Grayson PC, Kastner DL
    Mutant UBA1 and Severe Adult-Onset Autoinflammatory Disease. Reply.
    N Engl J Med. 2021;384:2164-2165.
    >> Share

  90. LUZZATTO L, Risitano AM, Notaro R
    Mutant UBA1 and Severe Adult-Onset Autoinflammatory Disease.
    N Engl J Med. 2021;384:2164.
    >> Share

  91. DIARRA A, Duployez N, Terriou L
    Mutant UBA1 and Severe Adult-Onset Autoinflammatory Disease.
    N Engl J Med. 2021;384:2163-2164.
    >> Share

  92. ARLET JB, Terrier B, Kosmider O
    Mutant UBA1 and Severe Adult-Onset Autoinflammatory Disease.
    N Engl J Med. 2021;384:2163.
    >> Share

  93. TUTT ANJ, Garber JE, Kaufman B, Viale G, et al
    Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer.
    N Engl J Med. 2021 Jun 3. doi: 10.1056/NEJMoa2105215.
    >> Share

    May 2021
  94. PUERTA-PENA M, Velasco-Tamariz V
    Herpes-Associated Erythema Multiforme.
    N Engl J Med. 2021;384:1848.
    >> Share

  95. MOHAMED F, Raal FJ
    Hyperpigmentation from Addison's Disease.
    N Engl J Med. 2021;384:1752.
    >> Share

    April 2021
  96. REICH K, Warren RB, Lebwohl M, Gooderham M, et al
    Bimekizumab versus Secukinumab in Plaque Psoriasis.
    N Engl J Med. 2021 Apr 23. doi: 10.1056/NEJMoa2102383.
    >> Share

  97. WARREN RB, Blauvelt A, Bagel J, Papp KA, et al
    Bimekizumab versus Adalimumab in Plaque Psoriasis.
    N Engl J Med. 2021 Apr 23. doi: 10.1056/NEJMoa2102388.
    >> Share

  98. YOON MK, Kelly HR, Freitag SK, Marneros AG, et al
    Case 12-2021: A 78-Year-Old Man with a Rash on the Scalp and Face.
    N Engl J Med. 2021;384:1553-1562.
    >> Share

  99. BARDIA A, Hurvitz SA, Tolaney SM, Loirat D, et al
    Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer.
    N Engl J Med. 2021;384:1529-1541.
    >> Share

  100. KLEIN B, Treudler R
    Palmoplantar Papules.
    N Engl J Med. 2021;384:1447.
    >> Share

  101. ADAMSON AS, Mazer BL, Welch HG
    The Rapid Rise in Cutaneous Melanoma Diagnoses. Reply.
    N Engl J Med. 2021;384:e54.
    >> Share

  102. GOLDSMITH SM
    The Rapid Rise in Cutaneous Melanoma Diagnoses.
    N Engl J Med. 2021;384:e54.
    >> Share

  103. GROSSMAN D, Sweeney C, Doherty JA
    The Rapid Rise in Cutaneous Melanoma Diagnoses.
    N Engl J Med. 2021;384:e54.
    >> Share

  104. ALVAREZ-ARANGO S, Ogunwole SM, Sequist TD, Burk CM, et al
    Vancomycin Infusion Reaction - Moving beyond "Red Man Syndrome".
    N Engl J Med. 2021;384:1283-1286.
    >> Share

  105. COHN A, Nehs M, Chan J, Vaidya A, et al
    Casting a Wide Net.
    N Engl J Med. 2021;384:e50.
    >> Share

  106. MCINNES IB, Anderson JK, Magrey M, Merola JF, et al
    Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis.
    N Engl J Med. 2021;384:1227-1239.
    >> Share

    March 2021
  107. STANDER S
    Atopic Dermatitis.
    N Engl J Med. 2021;384:1136-1143.
    >> Share

  108. BIEBER T, Simpson EL, Silverberg JI, Thaci D, et al
    Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis.
    N Engl J Med. 2021;384:1101-1112.
    >> Share

  109. BURSTEIN HJ
    Systemic Therapy for Estrogen Receptor-Positive, HER2-Negative Breast Cancer. Reply.
    N Engl J Med. 2021;384:1176-1177.
    >> Share

  110. COPUR MS
    Systemic Therapy for Estrogen Receptor-Positive, HER2-Negative Breast Cancer.
    N Engl J Med. 2021;384:1176.
    >> Share

  111. BENDAPUDI PK, Whalen MJ, Lahoud-Rahme M, Villalba JA, et al
    Case 7-2021: A 19-Year-Old Man with Shock, Multiple Organ Failure, and Rash.
    N Engl J Med. 2021;384:953-963.
    >> Share

    February 2021
  112. BLAUVELT A, Kempers S, Lain E, Schlesinger T, et al
    Phase 3 Trials of Tirbanibulin Ointment for Actinic Keratosis.
    N Engl J Med. 2021;384:512-520.
    >> Share

  113. FIJEN LM, Stroes ESG, Cohn DM
    Control of Hereditary Angioedema. Reply.
    N Engl J Med. 2021;384:e11.
    >> Share

  114. WANG C
    Control of Hereditary Angioedema.
    N Engl J Med. 2021;384:e11.
    >> Share

  115. HOUCHENS N, Hartley S, Commins SP, Claar D, et al
    Hunting for a Diagnosis.
    N Engl J Med. 2021;384:462-467.
    >> Share

    January 2021
  116. GAL MS, Greenberger S
    A Pulsating Leg.
    N Engl J Med. 2021;384:e8.
    >> Share

  117. MOON JH, Huynh J
    Pathergy in Neutrophilic Dermatosis.
    N Engl J Med. 2021;384:271.
    >> Share

  118. DORLING L, Carvalho S, Allen J, Gonzalez-Neira A, et al
    Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women.
    N Engl J Med. 2021 Jan 20. doi: 10.1056/NEJMoa1913948.
    >> Share

  119. NAROD SA
    Which Genes for Hereditary Breast Cancer?
    N Engl J Med. 2021 Jan 20. doi: 10.1056/NEJMe2035083.
    >> Share

  120. HU C, Hart SN, Gnanaolivu R, Huang H, et al
    A Population-Based Study of Genes Previously Implicated in Breast Cancer.
    N Engl J Med. 2021 Jan 20. doi: 10.1056/NEJMoa2005936.
    >> Share

  121. WELCH HG, Mazer BL, Adamson AS
    The Rapid Rise in Cutaneous Melanoma Diagnoses.
    N Engl J Med. 2021;384:72-79.
    >> Share

  122. RUDDER M, Russo M, Ventetuolo CE
    Breathing for Two.
    N Engl J Med. 2021;384:61-68.
    >> Share

    December 2020
  123. KOVITWANICHKANONT T, Darling M
    Acquired Hypertrichosis Lanuginosa.
    N Engl J Med. 2020;383:e144.
    >> Share

  124. BECK DB, Ferrada MA, Sikora KA, Ombrello AK, et al
    Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease.
    N Engl J Med. 2020;383:2628-2638.
    >> Share

  125. BURSTEIN HJ
    Systemic Therapy for Estrogen Receptor-Positive, HER2-Negative Breast Cancer.
    N Engl J Med. 2020;383:2557-2570.
    >> Share

  126. LEMAITRE S, Arora A
    Iridociliary Melanoma.
    N Engl J Med. 2020;383:e133.
    >> Share

    November 2020
  127. GONZAGA Y, Fontes M
    Blastic Plasmacytoid Dendritic-Cell Neoplasm.
    N Engl J Med. 2020;383:2158.
    >> Share

  128. BALWANI M, Sardh E, Gouya L
    Givosiran for Acute Intermittent Porphyria. Reply.
    N Engl J Med. 2020;383:1989-1990.
    >> Share

  129. GOMA-GARCES E, Perez-Gomez MV, Ortiz A
    Givosiran for Acute Intermittent Porphyria.
    N Engl J Med. 2020;383:1989.
    >> Share

  130. COOK D, Napthali K
    Pseudomelanosis Duodeni.
    N Engl J Med. 2020;383:e113.
    >> Share

    October 2020
  131. SCHRODER SD, Griebl SW
    Zinc Deficiency-Associated Dermatitis.
    N Engl J Med. 2020;383:e103.
    >> Share

  132. YASUDA MR, Roller LA, Fagenholz PJ, Hoang MP, et al
    Case 33-2020: A 55-Year-Old Man with Abdominal Pain, Joint Swelling, and Skin Lesions.
    N Engl J Med. 2020;383:1664-1671.
    >> Share

  133. GOYAL A, Blaes A
    Trichomegaly Associated with Panitumumab.
    N Engl J Med. 2020;383:e94.
    >> Share

  134. GO JR, Abu Saleh OM
    Vancomycin-Induced Linear IgA Bullous Dermatosis.
    N Engl J Med. 2020;383:1577.
    >> Share

  135. BERNSTEIN JA, Singh U, Rao MB, Berendts K, et al
    Benralizumab for Chronic Spontaneous Urticaria.
    N Engl J Med. 2020;383:1389-1391.
    >> Share

  136. BHUGRA P, Maiti A
    Secondary Syphilis.
    N Engl J Med. 2020;383:1375.
    >> Share

    September 2020
  137. COHN DM, Viney NJ, Fijen LM, Schneider E, et al
    Antisense Inhibition of Prekallikrein to Control Hereditary Angioedema.
    N Engl J Med. 2020;383:1242-1247.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016